Bioengineering (Jul 2021)

De Novo Valve Tissue Morphology Following Bioscaffold Mitral Valve Replacement in a Juvenile Non-Human Primate Model

  • Brittany A. Gonzalez,
  • Marcos Perez Gonzalez,
  • Frank Scholl,
  • Steven Bibevski,
  • Elena Ladich,
  • Jennifer Bibevski,
  • Pablo Morales,
  • Jesus Lopez,
  • Mike Casares,
  • Vincent Brehier,
  • Lazaro Hernandez,
  • Sharan Ramaswamy

DOI
https://doi.org/10.3390/bioengineering8070100
Journal volume & issue
Vol. 8, no. 7
p. 100

Abstract

Read online

The utility of implanting a bioscaffold mitral valve consisting of porcine small intestinal submucosa (PSIS) in a juvenile baboon model (12 to 14 months old at the time of implant; n = 3) to assess their in vivo tissue remodeling responses was investigated. Our findings demonstrated that the PSIS mitral valve exhibited the robust presence of de novo extracellular matrix (ECM) at all explantation time points (at 3-, 11-, and 20-months). Apart from a significantly lower level of proteoglycans in the implanted valve’s annulus region (p p > 0.05) found between any of the other principal valve ECM components (collagen and elastin) at the leaflet, annulus, or chordae tendinea locations, across these time points. In particular, neochordae tissue had formed, which seamlessly integrated with the native papillary muscles. However, additional processing will be required to trigger accelerated, uniform and complete valve ECM formation in the recipient. Regardless of the specific processing done to the bioscaffold valve, in this proof-of-concept study, we estimate that a 3-month window following bioscaffold valve replacement is the timeline in which complete regeneration of the valve and integration with the host needs to occur.

Keywords